Molecular diagnostics plays an increasingly important role in medicine for the detection of genetic diseases, the monitoring of the effectiveness of anti-cancer therapy, and in the fight against aggressive bacterial infections. Curiosity Diagnostics (CD), a company belonging to the Scope Fluidics group, has developed a new technique for DNA analysis: synergistic PCR (sPCR). The method, described in detail in the joint publication of CD and IPC PAS researchers in Scientific Reports combines the advantages of two of today’s most popular genetic code analysis techniques and can be carried out on widely available instruments.